About MGI Pharma
MGI Pharma is a company based in Woodcliff Lake (United States) founded in 1979 was acquired by Eisai in December 2007. MGI Pharma has completed 3 acquisitions, including Aesgen, Guildford Pharmaceuticals and Zycos.
- Headquarter Woodcliff Lake, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of MGI Pharma
Detailed funding history for MGI Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in MGI Pharma
MGI Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Eisai.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drugs for oncology and neurological disorders are developed by Eisai.
|
Locked | Locked | Locked |
Investor details for MGI Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MGI Pharma
MGI Pharma has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Aesgen, Guildford Pharmaceuticals and Zycos.
Investment portfolio details for MGI Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Limited information available
|
Locked | Locked | 1999 | Locked | |
|
A US-based specialty pharmaceutical company developing small molecule therapeutics for cancer and neurology.
|
Locked | Locked | 1996 | Locked | |
|
Limited information available
|
Locked | Locked | 1994 | Locked |
Complete acquisition details for MGI Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - MGI Pharma
Detailed financials for MGI Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mgi Pharma Comparisons
Peer comparison for MGI Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MGI Pharma
Detailed competitors of MGI Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mgi Pharma
Complete news archive for MGI Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MGI Pharma
MGI Pharma was founded in 1979.
MGI Pharma is headquartered in Woodcliff Lake, United States. It is registered at Woodcliff Lake, New Jersey, United States.
The company was founded in 1979 in Woodcliff Lake, United States, and focused on the pharmaceutical sector, particularly oncology and acute care applications. Pharmaceutical products were developed and commercialized, including Aloxi injection, Dacogen for injection, and Gliadel Wafer. Operations were conducted under the name Molecular Genetics Inc. until 1990, when it became MGI Pharma. Acquisition by Eisai Holdings US subsidiary occurred in 2008.
MGI Pharma has made 3 acquisitions, including Aesgen, Guildford Pharmaceuticals, and Zycos.
MGI Pharma has 1 investor. Key investors include Eisai.